Distinct roles of KLF4 in mesenchymal cell subtypes during lung fibrogenesis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34893592.
- Also identified by DOI 10.1038/s41467-021-27499-8 and PMC identifier 8664937.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
During lung fibrosis, the epithelium induces signaling to underlying mesenchyme to generate excess myofibroblasts and extracellular matrix; herein, we focus on signaling in the mesenchyme. Our studies indicate that platelet-derived growth factor receptor (PDGFR)-β<sup>+</sup> cells are the predominant source of myofibroblasts and Kruppel-like factor (KLF) 4 is upregulated in PDGFR-β<sup>+</sup> cells, inducing TGFβ pathway signaling and fibrosis. In fibrotic lung patches, KLF4 is down-regulated, suggesting KLF4 levels decrease as PDGFR-β<sup>+</sup> cells transition into myofibroblasts. In contrast to PDGFR-β<sup>+</sup> cells, KLF4 reduction in α-smooth muscle actin (SMA)<sup>+</sup> cells non-cell autonomously exacerbates lung fibrosis by inducing macrophage accumulation and pro-fibrotic effects of PDGFR-β<sup>+</sup> cells via a Forkhead box M1 to C-C chemokine ligand 2-receptor 2 pathway. Taken together, in the context of lung fibrosis, our results indicate that KLF4 plays opposing roles in PDGFR-β<sup>+</sup> cells and SMA<sup>+</sup> cells and highlight the importance of further studies of interactions between distinct mesenchymal cell types.
Medical subject headings
- Kruppel-Like Factor 4
- Lung
- Mesenchymal Stem Cells
- Myofibroblasts